I have just published: our 3 best small capitalization shares to consider buying in April (Premium Selections)

Premium content of Motley Fool Hidden winners United Kingdom

Our best monthly purchases are now designed to highlight the three favorite purchases of our team, most of the most timely purchases of our growing list of small capitalization recommendations, to help fools build their shares of shares.

Why do we like: “Scientific judges (LSE: JDG) has a select and select group of manufacturers of specialized scientific teams of niche, growing from an investment vehicle of £ 4 million in 2003 to a business valued at more than £ 440 million by the market today. He has achieved this growth with a common and intelligent sensation approach for acquisitions: buying leading companies in the world that have “a range of established products, an international profile of sustainable customers and sales, profits and cash generation.”

“The Executive President, David Cicurel, founded the company and has led it since then, sticking to his method of acquiring companies such as these in a very selectively The damn management, which includes the acquisition, which includes the acquisition, which includes the acquisition, which includes the team, which includes the acquisition, which includes the team, which includes the acquisition, which includes, which includes the management team, which includes the acquisition, which includes, the acquisition, which includes the team, which includes the team, which includes, the acquisition, which includes the acquisition, which includes the acquisition Management, which includes the acquisition, which includes. Halmaand Judges Operations Director since 2017. “

Why do we like now: The scientific judges experienced a challenging year in 2024, affected by the delayed expedition of Geotek Coring and the generally weak order intake, particularly China. However, the price of the action has already been reduced by half and seems to have reacted exaggeratedly. The performance of 2025 so far is in line with the expectations of the Board, backed by the Japanese centers contract and a “healthy” Order-book. We recommend buying in the sauce in anticipation of a profit recovery in 2025. Currently, the analysts' consensus forecasts are for the growth of income of 11% for the judges in 2025.